Pharmacometabolomic Approach to Investigate the Response to Metformin in Patients with Type 2 Diabetes: A Cross-Sectional Study

Metformin constitutes the foundation therapy in type 2 diabetes (T2D). Despite its multiple beneficial effects and widespread use, there is considerable inter-individual variability in response to metformin. Our objective is to identify metabolic signatures associated with poor and good responses to...

Descripción completa

Detalles Bibliográficos
Autores principales: Naja, Khaled, Anwardeen, Najeha, Al-Hariri, Moustafa, Al Thani, Asmaa A., Elrayess, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452592/
https://www.ncbi.nlm.nih.gov/pubmed/37626661
http://dx.doi.org/10.3390/biomedicines11082164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452592/
https://www.ncbi.nlm.nih.gov/pubmed/37626661
http://dx.doi.org/10.3390/biomedicines11082164

Ejemplares similares